Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Выбор терапии болевых форм диабетической полинейропатии нижних конечностей: традиционная концепция или индивидуализированный подход?
Выбор терапии болевых форм диабетической полинейропатии нижних конечностей: традиционная концепция или индивидуализированный подход?
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Daousi C, MacFarlane I, Woodward A et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 2004; 21: 976–82.
2. Davies M, Brophy S, Williams R et al. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006; 29: 1518–22.
3. Schmader K. Epidemiology and impact on quality of life of postherpetik neuralgia and painful diabetic neuropathy. Clin J Pain 2002; 18: 350–4.
4. Benbow S, Chan A, Bowsher D et al. A prospective study of painful symptoms, small-fibre function and peripheral vascular disease in chronic painful diabetic neuropathy. Diabet Med 1994; 11: 17–21.
5. Lopes L, Lins C, Adeodato V et al. Restless legs syndrome and quality of sleep in type 2 diabetes. Diabetes Care 2005; 28: 2633–36.
6. Tolle T, Xu X, Sadosky A. Painful diabetic neuropathy: cross-sectional survey of health state impairment and treatment patterns. J Diab Compl 2006; 20: 26–33.
7. Tesfaye S, Boulton A, Dyck P. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33: 2285–93.
8. Tesfaye S, Vileikyte L, Rayman G et al. Toronto Expert Panel on Diabetic Neuropathy. Painful Diabetic Peripheral Neuropathy: Consensus Recommendations on Diagnosis, Assessment and Management. Diabet Metab Res Rev 2011; 27: 629–38.
9. Баринов А.Н. Лечение невропатических болевых синдромов. Рус. мед. журн. 2006; 14 (9): 665–9.
10. Кукушкин М.Л. Патофизиологические механизмы болевых синдромов. Боль. 2003; 1: 6–12.
11. Левин О.С. Полиневропатии. Клиническое руководство. 2005. М.: МИА.
12. Vinik A. Clinical review: use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy. J Clin Endocr Metab 2005; 90: 4936–45.
13. Attal N, Cruccu G, Baron R et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17: 1113–88.
14. Bril V, England J, Franklin G et al. Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011; 76: 1758–65.
15. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 5-й выпуск. Сахарный диабет. 2011; 3 (Прил.).
16. Shakher J, Stevens M. Update on the management of diabetic polyneuropathies. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2011; 4: 289–305.
17. Manenti L, Vaglio A, Costantino E et al. Gabapentin in the treatment of uremic itch: an index case and a pilot evaluation.
J Nephrol 2005; 18 (1): 86–91.
18. Boulton A, Freeman R, D’Urso De Cruz. Are patient characteristics predictive of a response to pregabalin? Analysis from 5 randomized, placebo-controlled trials in painful diabetic peripheral neuropathy. Diabetologia 2006; 49 (Suppl. 1): 668–9.
19. Ziegler D. Painful diabetic neuropathy: advantage of novel drugs over old drugs? Diabetes Care 2009; 32 (Suppl. 2): 414–9.
2. Davies M, Brophy S, Williams R et al. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006; 29: 1518–22.
3. Schmader K. Epidemiology and impact on quality of life of postherpetik neuralgia and painful diabetic neuropathy. Clin J Pain 2002; 18: 350–4.
4. Benbow S, Chan A, Bowsher D et al. A prospective study of painful symptoms, small-fibre function and peripheral vascular disease in chronic painful diabetic neuropathy. Diabet Med 1994; 11: 17–21.
5. Lopes L, Lins C, Adeodato V et al. Restless legs syndrome and quality of sleep in type 2 diabetes. Diabetes Care 2005; 28: 2633–36.
6. Tolle T, Xu X, Sadosky A. Painful diabetic neuropathy: cross-sectional survey of health state impairment and treatment patterns. J Diab Compl 2006; 20: 26–33.
7. Tesfaye S, Boulton A, Dyck P. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33: 2285–93.
8. Tesfaye S, Vileikyte L, Rayman G et al. Toronto Expert Panel on Diabetic Neuropathy. Painful Diabetic Peripheral Neuropathy: Consensus Recommendations on Diagnosis, Assessment and Management. Diabet Metab Res Rev 2011; 27: 629–38.
9. Баринов А.Н. Лечение невропатических болевых синдромов. Рус. мед. журн. 2006; 14 (9): 665–9.
10. Кукушкин М.Л. Патофизиологические механизмы болевых синдромов. Боль. 2003; 1: 6–12.
11. Левин О.С. Полиневропатии. Клиническое руководство. 2005. М.: МИА.
12. Vinik A. Clinical review: use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy. J Clin Endocr Metab 2005; 90: 4936–45.
13. Attal N, Cruccu G, Baron R et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17: 1113–88.
14. Bril V, England J, Franklin G et al. Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011; 76: 1758–65.
15. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 5-й выпуск. Сахарный диабет. 2011; 3 (Прил.).
16. Shakher J, Stevens M. Update on the management of diabetic polyneuropathies. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2011; 4: 289–305.
17. Manenti L, Vaglio A, Costantino E et al. Gabapentin in the treatment of uremic itch: an index case and a pilot evaluation.
J Nephrol 2005; 18 (1): 86–91.
18. Boulton A, Freeman R, D’Urso De Cruz. Are patient characteristics predictive of a response to pregabalin? Analysis from 5 randomized, placebo-controlled trials in painful diabetic peripheral neuropathy. Diabetologia 2006; 49 (Suppl. 1): 668–9.
19. Ziegler D. Painful diabetic neuropathy: advantage of novel drugs over old drugs? Diabetes Care 2009; 32 (Suppl. 2): 414–9.
Авторы
О.Е.Хуторная1,2, В.Б.Бреговский1,2, А.Г.Демина1,2, И.А.Карпова2, Е.Н.Гринева1
1. ФГБУ Федеральный центр сердца, крови и эндокринологии им. В.А.Алмазова, Санкт-Петербург;
2. Территориальный диабетологический центр СПб ГБУЗ ГКДЦ №1
1. ФГБУ Федеральный центр сердца, крови и эндокринологии им. В.А.Алмазова, Санкт-Петербург;
2. Территориальный диабетологический центр СПб ГБУЗ ГКДЦ №1
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.